To B or not to B? That is the question, for global mother-to-child HIV-1 transmission prevention programs

Clin Infect Dis. 2013 Feb;56(3):447-9. doi: 10.1093/cid/cis862. Epub 2012 Nov 30.

Authors

Fredrick Sawe, Shahin Lockman

PMID: 23204036
DOI: 10.1093/cid/cis862

No abstract available

Publication types

Comment

MeSH terms

Anti-HIV Agents / therapeutic use*
Female
HIV Infections / transmission*
Humans
Infectious Disease Transmission, Vertical / prevention & control*
Pregnancy

Substances

Anti-HIV Agents